Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gyldenløve

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The British Journal of Dermatology|June 29, 2021
Complete clearance of severe plaque psoriasis with 24 weeks of oral roflumilast therapyA Egeberg, H Meteran, M Gyldenløve, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2017
Validation of psoriasis severity classification based on use of topical or systemic treatmentA Egeberg, M Gyldenløve, C Zachariae, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 13, 2021
Recurrent injection-site reactions after incorrect subcutaneous administration of a COVID-19 vaccineM Gyldenløve, L Skov, C B Hansen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 12, 2014
Pseudoporphyria - a case reportM Gyldenløve, E Due, M F Jonkman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 27, 2022
Rapid clearing of refractory nummular dermatitis with oral roflumilast therapyM Gyldenløve, C Zachariae, J P Thyssen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 17, 2013
Low prevalence of positive skin pathergy testing in Danish patients with Behçet's diseaseM Gyldenløve, N Tvede, J L Larsen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2017
Drug concentration and antidrug antibodies in patients with psoriasis treated with adalimumab or etanerceptM Gyldenløve, C Zachariae, P Jensen, et al.
Journal of Internal Medicine|July 16, 2015
Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasisM Gyldenløve, T Vilsbøll, C Zachariae, et al.
The British Journal of Dermatology|March 31, 2015
Disturbed postprandial glucose metabolism and gut hormone responses in non-diabetic patients with psoriasisM Gyldenløve, T Vilsbøll, J J Holst, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 29, 2014
'Short-term treatment with methotrexate does not affect microvascular endothelial function in patients with psoriasis'M Gyldenløve, P Jensen, M B Løvendorf, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The British Journal of Dermatology|June 29, 2021
Complete clearance of severe plaque psoriasis with 24 weeks of oral roflumilast therapyA Egeberg, H Meteran, M Gyldenløve, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2017
Validation of psoriasis severity classification based on use of topical or systemic treatmentA Egeberg, M Gyldenløve, C Zachariae, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 13, 2021
Recurrent injection-site reactions after incorrect subcutaneous administration of a COVID-19 vaccineM Gyldenløve, L Skov, C B Hansen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 12, 2014
Pseudoporphyria - a case reportM Gyldenløve, E Due, M F Jonkman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 27, 2022
Rapid clearing of refractory nummular dermatitis with oral roflumilast therapyM Gyldenløve, C Zachariae, J P Thyssen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 17, 2013
Low prevalence of positive skin pathergy testing in Danish patients with Behçet's diseaseM Gyldenløve, N Tvede, J L Larsen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2017
Drug concentration and antidrug antibodies in patients with psoriasis treated with adalimumab or etanerceptM Gyldenløve, C Zachariae, P Jensen, et al.
Journal of Internal Medicine|July 16, 2015
Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasisM Gyldenløve, T Vilsbøll, C Zachariae, et al.
The British Journal of Dermatology|March 31, 2015
Disturbed postprandial glucose metabolism and gut hormone responses in non-diabetic patients with psoriasisM Gyldenløve, T Vilsbøll, J J Holst, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 29, 2014
'Short-term treatment with methotrexate does not affect microvascular endothelial function in patients with psoriasis'M Gyldenløve, P Jensen, M B Løvendorf, et al.
Pageof 2